L. H. Mckendry, M. A. Stanga
Dec 1, 1994
Citations
0
Influential Citations
0
Citations
Journal
Journal of Labelled Compounds and Radiopharmaceuticals
Abstract
Two new processes were developed for the synthesis of 2,6-dichloro-3-methylaniline-Ph-UL-14C (1), a key intermediate in the synthesis of a Dow Elanco experimental product presently being considered for commercialization. Both processes afford product in much higher yields than that previously reported in the literature. One of the processes was subsequently applied to the synthesis of methyl 6-chloroanthranilate-Ph-UL-14C (12), used as an intermediate for a second potential product.